CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,163,657)	$ (4,130,522)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	46,365	42,470
Non-cash interest expense	511,362	44,388
Fair value of common stock issued for consulting	30,000	178,160
Fair value of warrants issued as covenant settlement	80,472	0
Share-based compensation related to stock options	135,492	417,569
Gain on accounts payable settlement	(184,039)	(11,126)
Loss on fixed asset dispositions	0	29,596
Net loss on sale of trading securities	11,946	302,116
Change in unrealized loss on trading securities	(7,986)	(228,156)
Gain on revaluation and modification of derivative liabilities	(715,962)	(1,227,998)
(Increase) decrease in:
Prepaid expenses and other	(113,247)	(21,949)
Increase (decrease) in:
Accounts payable	616,676	914,808
Accrued expenses and other	75,689	369,225
Net Cash Used by Operating Activities	(2,676,889)	(3,321,419)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of investments	35,970	568,852
Cash paid for intangible assets	0	(350,000)
Cash paid for purchase of property and equipment	(6,694)	(6,564)
Net Cash Provided by Investing Activities	29,276	212,288
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible notes payable - short term	2,980,005	1,928,000
Proceeds from other short - term financing	365,000	150,000
Notes payable issuance costs	(168,690)	(128,329)
Repayment of notes payable	(490,000)	(25,000)
Proceeds from the exercise of stock	0	90,375
Proceeds from sale of common stock, net	0	203,055
Net Cash Provided by Financing Activities	2,686,315	2,218,101
Net Change in Cash and Cash Equivalents	38,702	(891,030)
Cash and Cash Equivalents, Beginning of Period	252,145	1,143,175
Cash and Cash Equivalents, End of Period	290,847	252,145
Supplemental Cash Flow Disclosures:
Interest expense paid in cash	3,543	0
Tax paid	1,912	1,412
Supplemental Non-Cash Disclosure:
Fair value of warrants modified in connection with Series B financing	0	33,121
Fair value of warrants issued to Series B placement agents	0	12,738
Notes payable issued for securities	0	47,916
Notes payable issued as accounts payable settlement	0	22,500
Series B Preferred Stock dividend	453,305	466,966
Series A Preferred Stock dividend	47,602	77,403
Accounts Payable settled in Common Stock	277,250	0
Prepaid consulting services paid in Common Stock	30,000	0
Conversion of Series A Preferred Stock dividend to common stock	17,033	17,170
Conversion of Series A preferred shares to common stock	1,923	1,494
Conversion of Series B Preferred Stock dividend to Common Stock	56,094	1,254
Conversion of Series B preferred shares to common stock	313	50
Fair value of warrants issued as covenant settlement	80,472	0
Fair value of derivative warrants issued with Convertible Notes	358,255	0
Fair value of derivative warrants issued to Convertible Notes placement agents	39,108	0
Fair value of embedded derivative liability in Convertible Notes	$ 490,340	$ 0